Clinical studies recruiting near Liuzhou

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Liuzhou People's Hospital · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Liuzhou People's Hospital ( Site 2029) · Merck Sharp & Dohme LLC · NCT06136559 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Liuzhou People's Hospital · Eli Lilly and Company · NCT06890598 A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Phase 1/Phase 2 · Liuzhou Workers' Hospital · Advenchen Laboratories, LLC · NCT07392736 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0412 · Celgene · NCT05519085 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Liuzhou People's Hospital · Boehringer Ingelheim · NCT06531824 A Study of MI078 for Postpartum Depression
Phase 3 · Guangxi Zhuang Autonomous Region Brain Hospital · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961 A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carc
Phase 3 · The Second Affiliated Hospital Of GXUST · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06860971 A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER
Phase 2/Phase 3 · Liuzhou People's Hospital · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06891833 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Liuzhou People's Hospital · Bristol-Myers Squibb · NCT06561386 Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NA · Liuzhou People's Hospital · Southeast University, China · NCT07726953 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Phase 2 · Liuzhou people's Hospital · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05872347 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Im
Phase 1/Phase 2 · Liuzhou People's hospital /ID# 269667 · AbbVie · NCT06772623 Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Phase 3 · Liuzhou People's Hospital · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06842199 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Liuzhou People's Hospital · Eli Lilly and Company · NCT06119581 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Comp
Phase 3 · Research Site · AstraZeneca · NCT07662044 A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
Phase 2 · Liuzhou People's Hospital · Kind Pharmaceuticals LLC · NCT06302491 Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Phase 3 · Liuzhou People's Hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07107256 Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06711887 Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma
NA · Liuzhou worker's Hospital · Beijing Tiantan Hospital · NCT07144423 Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
Phase N/A · Liuzhou People's Hospital · Southeast University, China · NCT07726940 The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatri
Phase 3 · Liuzhou People's Hospital · Oupushifang Pharmaceutical Technology Co., Ltd. · NCT06708156 Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
Phase 1/Phase 2 · Liuzhou People's Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06829771 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Local Institution - 007-704-Ph2 · Mirati Therapeutics Inc. · NCT04613596 A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
Phase N/A · The Fourth Affiliated Hospital of Guangxi Medical University · First Hospital of China Medical University · NCT07133516 Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · Liu Zhou Works Hospital · Vertex Pharmaceuticals Incorporated · NCT07204275 ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Phase 2 · Liuzhou People's Hospital · Abbisko Therapeutics Co, Ltd · NCT07327034 Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic
Phase 2/Phase 3 · Liuzhou people's Hospital · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05860465

Look up another city

Look up another condition